The project has started Phase III of the human trials to assess how
the vaccine works in a large number of people over the age of 18,
but has yet to report Phase I trial results.
The developers of the vaccine earlier this month said they are
encouraged by the immune response they have seen in trials so far.
[nL8N2E84YY]
"I am hearing there will be positive news soon (perhaps tomorrow) on
initial trials of the Oxford Covid-19 vaccine that is backed by
AstraZeneca," Peston said in a blog post on Wednesday.
(Reporting by William Schomberg, writing by Alistair Smout; editing
by Michael Holden)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |